ASLAN Pharmaceuticals Limited Gains 16.36%
Wed 23 Sep 20 at 05:33 PM
ASLAN Pharmaceuticals Limited (ASLN:NASDAQ) rocketted at $1.92, representing a gain of 16.4%. On Tue 22 Sep 20, ASLN:NASDAQ touched a New 2-Week High of $1.65. The stock appeared on our News Catalysts scanner on Thu 10 Sep 20 at 03:22 AM in the 'MISCELLANEOUS' category. From Tue 08 Sep 20, the stock recorded 70.00% Up Days and 63.64% Green Days
The share price of the company has been moving sideways in recent weeks.
About ASLAN Pharmaceuticals Limited (ASLN:NASDAQ)
ASLAN Pharmaceuticals Ltd is an oncology-focused biotechnology company developing a portfolio of immuno-oncology agents and targeted therapies. Its products include Varlitinib, ASLAN002, ASLAN003, ASLAN004, ASLAN005, and Modybodies.
Top 10 Gainers:
- SPI Energy Co., Ltd. (SPI:NASDAQ), 1259.22%
- Sunworks, Inc. (SUNW:NASDAQ), 50.38%
- Digital Ally, Inc. (DGLY:NASDAQ), 47.64%
- JinkoSolar Holding Co., Ltd. (JKS:NYSE), 20.97%
- Predictive Oncology Inc. (POAI:NASDAQ), 16.66%
- ASLAN Pharmaceuticals Limited (ASLN:NASDAQ), 16.36%
- AMWL (AMWL:NYSE), 15.38%
- Cemtrex, Inc. (CETX:NASDAQ), 12.8%
- Hilltop Holdings Inc. (HTH:NYSE), 12.48%
- Polar Power, Inc. (POLA:NASDAQ), 11.63%